Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma

@article{He2012PretreatmentLO,
  title={Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma},
  author={Jianxing He and Guo-Ping Shen and Ze-fang Ren and Han Qin and Cui Cui and Ying Zhang and Yi-Xin Zeng and Wei-Hua Jia},
  journal={Head \& Neck},
  year={2012},
  volume={34}
}
The purpose of this study was to evaluate the counts and percentages of differential leukocytes as prognostic indicators in patients with nasopharyngeal carcinoma (NPC). 
View on Wiley
sbccp.org.br
168 Citations
Highly Influential Citations
7
Background Citations
61
Methods Citations
6
Results Citations
5

168 Citations

Citation Type

Citation Type

Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer
The purpose of this study was to investigate whether the pretreatment total and differential leukocyte counts can predict the prognosis of patients with oral cavity cancer.
Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer
The purpose of this study was to analyze the prognostic value of pretreatment count of peripheral neutrophils, lymphocytes, monocytes, and neutrophil‐to‐lymphocyte ratio (NLR) in patients with head…
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio
TLDR
Pretreatment hematological markers of inflammatory response have emerged as prognostic factors for patients with cancer and their prognostic significance in patients with nasopharyngeal carcinoma is evaluated.
Pretreatment neutrophil‐to‐lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma
TLDR
The purpose of this study was to examine the impact of neutrophil‐to‐lymphocyte ratio (NLR) on survival in patients with metastatic NPC.
Prognostic value of the neutrophil‐to‐lymphocyte ratio in patients with laryngeal squamous cell carcinoma
TLDR
The neutrophil/lymphocyte ratio (NLR) has been found to be predictive of survival outcome in a range of tumors and this study investigated the prognostic value of pretreatment in patients with laryngeal squamous cell carcinoma.
Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer
The purpose of this study was to investigate whether the minimum absolute lymphocyte count (ALC) during radiotherapy (RT) could predict clinical outcome in patients with nasopharyngeal cancer (NPC).
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
The objective of this study was to investigate the prognostic value of the pretreatment circulating neutrophil count (CNC), circulating monocyte count (CMC), and circulating lymphocyte count (CLC) in…
Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratio
TLDR
This study presents the investigation of the value of neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to-lymphocytes ratio (PLR) in predicting recurrence and mortality for patients with primary sinonasal cancers (SNCs).
Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma
Current prognostic criteria are insufficient in predicting outcomes in head and neck cancer, necessitating new, readily available biomarkers.
Pretreated baseline neutrophil count and chemotherapy‐induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer
Increasing evidence suggests that neutrophils play a critical role in tumorigenesis, tumour cell proliferation and metastasis. The prognostic significance of such inflammation‐associated markers has…
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 46 REFERENCES
Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer
TLDR
This study aimed to determine if neutrophil‐to‐lymphocyte ratio (NLR) predicts survival in colorectal cancer patients.
The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer
TLDR
Measurement of this ratio may serve as a clinically accessible and useful biomarker for patient survival and suggest that the N/L ratio is an independent prognostic factor in advanced gastric cancer.
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma.
  • F. Donskov, H. von der Maase
  • Medicine, Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
TLDR
Three independent immunologic parameters had significant discriminatory power as supplemental risk factors in prognostic models based on the clinical risk factors, identifying subgroups within the favorable clinical group with estimated 5-year survival rates of 60%, 25%, and 0%, respectively.
The intriguing role of polymorphonuclear neutrophils in antitumor reactions.
Polymorphonuclear neutrophils (PMNs) are the most abundant circulating blood leukocytes. They provide the first-line defense against infection and are potent effectors of inflammation. In addition,…
Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
  • H. Schmidt, S. Suciu, +7 authors U. Keilholz
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
TLDR
A high pretreatment count of neutrophil and leukocytes in blood was confirmed as an independent prognostic factor for short overall survival in stage IV melanoma patients undergoing interleukin-2-based immunotherapy and both parameters should be useful as stratification factors in clinical trials.
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
TLDR
A prognostic model in metastatic melanoma based on independent prognostic factors in 321 patients receiving interleukin-2 (IL-2)-based immunotherapy with a median follow-up time for patients currently alive was created and an elevated monocyte count could replace an elevated neutrophil count.
Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
TLDR
Evidence is provided for the association between NLR and epithelial ovarian cancer and preoperative NLR, in combination with CA125, may represent a simple and cost-effective method of identifying ovarian cancers, and an elevated NLR may predict an adverse outcome in ovarian cancer.
Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma
TLDR
Multivariate analysis showed that a NLR ≥ 5 and R1 resection margin were independent predictors of poorer disease-free survival and overall survival in patients undergoing resection for HCC from January 1994 to May 2007.
Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma
TLDR
For patients with locoregionally advanced disease, NLR was not only an independent prognostic factor, but also a predictor of response to chemoradiotherapy, which significantly improved DSS and LRFS for patients with non-elevated NLR, but not for those with elevated NLR.
...
1
2
3
4
5
...